Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes - PubMed (original) (raw)
Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes
European Society of Human Genetics. Eur J Hum Genet. 2010 Dec.
Abstract
Many private companies offer direct-to-consumer (DTC) genetic testing services. Some tests may detect severe and highly penetrant monogenic disorders, while other tests are for genetic variants found associated with increased susceptibility for common and complex diseases in large-scale population studies. Through its Public and Professional Policy committee followed by member and expert consultation, the European Society of Human Genetics has developed the following policy on advertising and provision of predictive genetic tests by such DTC companies: (1) clinical utility of a genetic test shall be an essential criterion for deciding to offer this test to a person or a group of persons; (2) laboratories providing genetic tests should comply with accepted quality standards, including those regarding laboratory personnel qualifications; (3) information about the purpose and appropriateness of testing should be given before the test is done; (4) genetic counselling appropriate to the type of test and disease should be offered; and for some tests psychosocial evaluation and follow-up should be available; (5) privacy and confidentiality of sensitive genetic information should be secured and the data safely guarded; (6) special measures should be taken to avoid inappropriate testing of minors and other legally incapacitated persons; (7) all claims regarding genetic tests should be transparent; advertisement should be unbiased and marketing of genetic tests should be fair; (8) in biomedical research, health care and marketing, respect should be given to relevant ethical principles, as well as international treaties and recommendations regarding genetic testing; and (9) nationally approved guidelines considering all the above-mentioned aspects should be made and followed.
Similar articles
- Health-related direct-to-consumer genetic testing: a review of companies' policies with regard to genetic testing in minors.
Borry P, Howard HC, Sénécal K, Avard D. Borry P, et al. Fam Cancer. 2010 Mar;9(1):51-9. doi: 10.1007/s10689-009-9253-9. Epub 2009 Jun 2. Fam Cancer. 2010. PMID: 19488835 - Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value.
Mathews R, Hall W, Carter A. Mathews R, et al. Addiction. 2012 Dec;107(12):2069-74. doi: 10.1111/j.1360-0443.2012.03836.x. Epub 2012 Apr 17. Addiction. 2012. PMID: 22510165 - Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations.
Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K; Public and Professional Policy Committee (PPPC) of the European Society of Human Genetics (ESHG). Borry P, et al. Eur J Hum Genet. 2009 Jun;17(6):711-9. doi: 10.1038/ejhg.2009.25. Epub 2009 Mar 11. Eur J Hum Genet. 2009. PMID: 19277061 Free PMC article. - Current landscape of direct-to-consumer genetic testing and its role in ophthalmology: a review.
Sanfilippo PG, Kearns LS, Wright P, Mackey DA, Hewitt AW. Sanfilippo PG, et al. Clin Exp Ophthalmol. 2015 Aug;43(6):578-90. doi: 10.1111/ceo.12508. Epub 2015 Apr 27. Clin Exp Ophthalmol. 2015. PMID: 25676199 Review. - Ethical and clinical practice considerations for genetic counselors related to direct-to-consumer marketing of genetic tests.
Wade CH, Wilfond BS. Wade CH, et al. Am J Med Genet C Semin Med Genet. 2006 Nov 15;142C(4):284-92, discussion 293. doi: 10.1002/ajmg.c.30110. Am J Med Genet C Semin Med Genet. 2006. PMID: 17068807 Review.
Cited by
- Direct-to-consumer genetic testing in Slovenia: availability, ethical dilemmas and legislation.
Vrecar I, Peterlin B, Teran N, Lovrecic L. Vrecar I, et al. Biochem Med (Zagreb). 2015;25(1):84-9. doi: 10.11613/BM.2015.010. Biochem Med (Zagreb). 2015. PMID: 25672471 Free PMC article. - Common CYP2D6, CYP2C9, and CYP2C19 Gene Variants, Health Anxiety, and Neuroticism Are Not Associated With Self-Reported Antidepressant Side Effects.
Maggo S, Kennedy MA, Barczyk ZA, Miller AL, Rucklidge JJ, Mulder RT, Foulds JA. Maggo S, et al. Front Genet. 2019 Nov 26;10:1199. doi: 10.3389/fgene.2019.01199. eCollection 2019. Front Genet. 2019. PMID: 31850065 Free PMC article. - Closure of population biobanks and direct-to-consumer genetic testing companies.
Zawati MH, Borry P, Howard HC. Zawati MH, et al. Hum Genet. 2011 Sep;130(3):425-32. doi: 10.1007/s00439-011-1019-4. Epub 2011 Jun 26. Hum Genet. 2011. PMID: 21706343 Review. - Genetic testing: predictive value of genotyping for diagnosis and management of disease.
Ozgüç M. Ozgüç M. EPMA J. 2011 Jun;2(2):173-9. doi: 10.1007/s13167-011-0077-y. Epub 2011 May 6. EPMA J. 2011. PMID: 23199147 Free PMC article. - Pregnancy Planning and Genetic Testing: Exploring Advantages, and Challenges.
Kristoffersson U, Johansson-Soller M. Kristoffersson U, et al. Genes (Basel). 2024 Sep 13;15(9):1205. doi: 10.3390/genes15091205. Genes (Basel). 2024. PMID: 39336796 Free PMC article. Review.
References
- Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Genetic Testing for Health PurposesCouncil of Europe, Strasbourg, 2008. Available from http://conventions.coe.int/Treaty/EN/ Treaties/Html/203.htm . - PubMed
- Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devicesAvailable from http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri= CELEX:31998L0079:... .
MeSH terms
LinkOut - more resources
Full Text Sources
Medical